本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

7.69
+0.13001.72%
盘后7.690.00000.00%17:21 EDT
成交量:83.75万
成交额:638.58万
市值:4.16亿
市盈率:-4.67
高:7.72
开:7.55
低:7.34
收:7.56
数据加载中...
2025/03/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/19

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

重要事件披露

Form 8-K - Current report
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/23

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities